ISMP Canada News

April 6, 2021: Health Canada has initiated a safety review on Xeljanz and Xeljanz XR (tofacitinib), used to treat arthritis and ulcerative colitis

Health Canada has initiated a safety review on Xeljanz and Xeljanz XR (tofacitinib), used to treat arthritis and ulcerative colitis" trackback:ping="https://www.ismp-canada.org/news/bblog/trackback.php/493/" />